ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 661746 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 661746; 2) Community: the network communities that were significantly associated with the response to NSC 661746; 3) Molecule: the relationships between components within communities and NSC 661746; 4) MDR: the compounds that were significantly associated with the NSC 661746.

NSC Compound Enrichment Correlation
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.0385203205529756 0.19964387
NSC 754088 7-(3-nitro-4-methoxybenzyl)-6-(3,4,5-trimethoxyphenyl)-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole 0.0385203205529756 0.15986008
NSC 755443 Null 0.0385203205529756 0.22228051
NSC 757113 METHOTREXATE(+/-) 0.0385203205529756 0.24115791
NSC 106969 CENTAUREIDIN 0.0385203205529759 0.25809422
NSC 107124 Camptothecin Derivative 0.0385203205529759 0.093607453
NSC 109836 Null 0.0385203205529759 0.48545461
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0385203205529759 0.22949704
NSC 158263 Indoline, 5-chloro-1,3,3-trimethyl-2-methylene- (8CI) 0.0385203205529759 0.24494263
NSC 175490 Iron, carbonyl(.eta.5-2,4-cyclopentadien-1-yl)(di-4-morpholinylcarbamodithioato-S,S')- 0.0385203205529759 0.36723815
Total:82  Current:63    [First] [Prev] [Next] [Last]